Clinical trials
Treatment clinical trials
Below are recruiting treatment clinical trials, each written for real people, not researchers. We’re tracking 8,312 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07776873RecruitingPhase 3
Clot-busting medicine for stroke symptoms 4.5 to 24 hours
This study tests a clot-busting medicine given through an IV to people who had a stroke caused by a blocked medium-sized blood vessel in the brain, and who can be treated 4.5 to 24 hours after symptoms start. The goal is to see if it improves recovery and reduces disability compared to standard care.
Hefei, AnhuiAges 18 years+ - NCT07777783Recruiting
Non-surgical treatment for breast abscess
This study tests whether draining a breast abscess with a needle and using antibiotics can treat it without surgery. It may be a gentler option for women with this condition.
SohagAges 18 years+ - NCT07781358RecruitingPhase 2
Testing a new drug combination for recurrent nasopharyngeal cancer
This trial tests a new drug combination for people whose nasopharyngeal cancer has come back in the same area or nearby lymph nodes. The goal is to see if this treatment can shrink or control the cancer.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT07778212Recruiting
New drug combo for aggressive lymphoma
This trial tests a new combination of drugs for people newly diagnosed with an aggressive type of lymphoma called diffuse large B-cell lymphoma (DLBCL). The combo includes orelabrutinib plus standard chemo-immunotherapy, and may help improve outcomes for those at intermediate or high risk.
Xiamen, FujianAges 18 years+ - NCT07779343Recruiting
Multidisciplinary support for adults living with obesity
This study tests a programme that combines medical, dietary, and behavioural support to help adults with obesity lose weight and improve their health. It looks at how well the programme works in everyday clinic settings.
AlgiersAges 18–65 - NCT07780929Recruiting
Study of XJH05 ointment for mild-to-moderate plaque psoriasis
This trial tests a new ointment (XJH05) for people with mild-to-moderate plaque psoriasis. It aims to see if this treatment helps reduce symptoms and is safe for topical use.
Xi'an, ShaanxiAges 18–65 - NCT07783412RecruitingPhase 2
Topical ruxolitinib cream for pyoderma gangrenosum ulcers
This study tests a cream called ruxolitinib to treat pyoderma gangrenosum, a painful skin condition that causes deep ulcers. The cream is applied directly to the ulcer and may help it heal without the side effects of pills or injections.
Portland, OregonAges 18–99 - NCT07782684Recruiting
Recovery of immune cells after cord blood transplant
This study looks at how a type of immune cell called gamma-delta T cells recovers in your body after a cord blood transplant. It may help doctors understand how to improve recovery and reduce complications.
Hefei, AnhuiAges Any age - NCT04619277Recruiting
Drug-coated balloon for a new coronary artery blockage
This trial studies whether a drug-coated balloon can treat a brand-new (de novo) blockage in the coronary arteries. If you may qualify, it could offer a way to reduce problems from this blockage using a device that delivers medicine during treatment.
UlsanAges Any age - NCT06555237RecruitingPhase 2
MEK inhibitors for heart thickening in RASopathies
This trial tests a targeted drug (MEK inhibitor) to treat thickened heart muscle caused by a group of genetic conditions called RASopathies. It may help improve heart function in people with hypertrophic cardiomyopathy.
WarsawAges 1 day–18 years - NCT02098252Recruiting
Study for treating brain blood vessel malformations (AVMs)
This study is looking at treatment options for people who have an abnormal cluster of blood vessels in the brain (an AVM). It may help participants by offering a structured treatment approach, depending on the AVM type and recent symptoms.
Jacksonville, FloridaAges 5 years+ - NCT05316805Recruiting
Study for type 2 inflammatory skin rashes and hives
This study looks at people with certain types of inflammatory skin conditions to improve how they are diagnosed and treated. It may help your care team by using a standardized approach, but you must be able to complete questionnaires and consent to participate.
BeijingAges Any age - NCT06414135RecruitingPhase 1
CAR-T therapy for people with diffuse scleroderma
This trial tests a new CAR-T cell therapy called relmacabtagene autoleucel for people with diffuse systemic sclerosis (scleroderma) that is not responding to standard treatments. The goal is to see if this therapy can help control the disease.
ShanghaiAges 18–65 - NCT06554600RecruitingPhase 2
Study of zanubrutinib plus polatuzumab, bendamustine, and rituximab for relapsed DLBCL
This trial tests a combination of targeted drugs and chemotherapy for patients whose large B-cell lymphoma has returned or not improved after first treatment. The goal is to see if this mix works better than standard options.
Hanzhou, ZhejiangAges 18–75 - NCT06428422Recruiting
Probiotic supplement for advanced lung cancer
This trial tests if taking a probiotic supplement along with your standard lung cancer treatment can help you live longer and respond better to therapy. It is for people with advanced non-small cell lung cancer who have not tried immunotherapy before.
KonyaAges 19–90 - NCT04660747Recruiting
Anticoagulant medication choices for cerebral venous thrombosis
This study looks at people with cerebral venous thrombosis who were treated with blood thinners taken by mouth (or started within the first 30 days). It uses observational data to understand how these treatments are used and what outcomes may follow.
Amsterdam, North HollandAges 18 years+ - NCT05215535Recruiting
Liver MRI before rectal cancer treatment
This trial tests whether doing an MRI scan of the liver before rectal cancer treatment helps doctors plan care better. You may be asked to have MRI before starting treatment and follow the study plan.
GothenburgAges 18 years+ - NCT04989491RecruitingPhase 4
Single-dose rituximab to prevent EBV after kidney transplant
This trial tests whether one dose of rituximab (given around the time of transplant) can help prevent a first Epstein-Barr virus (EBV) infection and related abnormal lymph node or immune growths after kidney transplant. It is specifically for adults who are EBV-negative before receiving an EBV-positive donor kidney.
StrasbourgAges 18 years+ - NCT05845723RecruitingPhase 2
Study drugs for blood-vessel Behçet’s to reduce inflammation
This Phase 2 trial tests tocilizumab and tofacitinib to see if they can better control vascular (blood-vessel) Behçet’s syndrome. It may help by lowering inflammation and reducing complications from aneurysms in the aorta or peripheral arteries.
Beijing, Beijing MunicipalityAges 18–65 - NCT06187441RecruitingPhase 3
Testing a treatment break in multiple myeloma
This trial is for people with multiple myeloma who have already completed 12 cycles of a standard treatment (daratumumab, lenalidomide, and dexamethasone) and are doing well. It tests whether taking a break from treatment is safe and effective, instead of continuing without a break.
's-HertogenboschAges 18 years+ - NCT06176534RecruitingPhase 2
Comparing two treatments for advanced breast cancer with low hormone receptor
This trial compares two treatment options for advanced breast cancer that has low hormone receptor levels and is HER2-negative. It tests whether a combination of chemotherapy followed by maintenance therapy works better than a CDK4/6 inhibitor combined with hormone therapy. This is for people who have not had chemotherapy for their advanced disease.
Zhengzhou, HenanAges 18 years+ - NCT06562062Recruiting
New surgery for flexible flat foot
This study tests a modified surgical technique to fix a painful, flexible flat foot in adults who haven't improved with nonsurgical care. It may help by repairing a key ligament on the outside of the knee to support the arch.
Asyut, AssiuuAges 16–65 - NCT06562920RecruitingPhase 2
Immunotherapy plus chemo and SBRT before surgery for limited-stage small cell lung cancer
This trial tests a combination of immunotherapy (adebrelimab), chemotherapy, and targeted radiation (SBRT) before surgery for people with limited-stage small cell lung cancer. The goal is to see if this approach can shrink tumors and improve outcomes before the main treatment.
Hangzhou, ZhejiangAges 18–75 - NCT04372485Recruiting
Text-message support to help teens finish STI antibiotics
This trial tests whether a mobile phone text-message program can help teens stick to their outpatient antibiotic treatment for common sexually transmitted infections (STIs). It may help improve cure rates by supporting correct medication timing and completion.
Washington D.C., District of ColumbiaAges 15–21
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment?
- Yes. Clin2 currently lists 8,312 recruiting treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.